# Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy

> **NCT04445948** · PHASE4 · COMPLETED · sponsor: **Alexandria University** · enrollment: 400 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Esomeprazole 40 milligrams Oral Tablet
- **DRUG:** Amoxicillin 1000 milligrams tablets
- **DRUG:** Clarithromycin 500 milligrams Tablets
- **DRUG:** MetroNIDAZOLE 500 milligrams Oral Tablet
- **DRUG:** Lactoferrin Bovine sachets 200 milligrams

## Key facts

- **NCT ID:** NCT04445948
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-30
- **Primary completion:** 2020-06-21
- **Final completion:** 2020-06-21
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2020-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04445948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04445948, "Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04445948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*